$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

미슬토 추출물 투여와 병행한 한방치료를 통해 호전된 재발성 자궁경부상피내종양 증례보고
A Case Report of Recurrent Cervical Intraepithelial Neoplasia Treated by Korean Traditional Medicine and Mistletoe Extract Inject 원문보기

大韓韓方婦人科學會誌 = The Journal of Korean obstetrics & gynecology, v.35 no.4, 2022년, pp.174 - 185  

고은빈 (경희대학교 대학원 임상한의학과) ,  박남경 (경희대학교 대학원 임상한의학과) ,  최민영 (경희대학교 대학원 임상한의학과) ,  이진무 (경희대학교 대학원 임상한의학과) ,  이창훈 (경희대학교 대학원 임상한의학과) ,  장준복 (경희대학교 대학원 임상한의학과) ,  황덕상 (경희대학교 대학원 임상한의학과)

Abstract AI-Helper 아이콘AI-Helper

Objectives: The purpose of this study is to report the improvement of recurrent cervical intraepithelial neoplasia (CIN) and chief complaint including dysmenorrhea, premenstrual syndrome after Korean medicine treatment. Methods: The patient who diagnosed CIN even after undergoing two times of loop e...

주제어

표/그림 (4)

참고문헌 (39)

  1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. 

  2. National Center Information Cancer. Annual report of cancer statistics in Korea in 2019 [cited May 23 2022]. Available from:URL:https://www.cancer.go.kr 

  3. Korean Society of Obstetrics and Gynecology. Gynecology. 6th edition. Paju:Koonja. 2021:140, 365-99, 771. 

  4. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12(2):186-92. 

  5. McCredie MR, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425-34. 

  6. Addis IB, Hatch KD, Berek JS. Intraepithelial disease of the cervix, vagina, and vulva. In: Berek JS, editor. Berek & Novak's gynecology. 14th ed. Philadelphia:Lippincott Williams & Wilkins. 2007:561-600. 

  7. Zielinski GD, et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv. 2004;59(7):543-53. 

  8. Verguts J, et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. British Journal of Obstetrics and Gynaecology. 2006;113(11):1303-7. 

  9. Alonso I, et al. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision procedure: follow-up and value of human papillomavirus testing. American Journal of Obstetrics and Gynecology. 2007;197(4):359.e1-6. 

  10. Lima MIM, et al. Cervical intraepithelial neoplasia recurrence after conization in HIV-positive and HIV-negative women. International Journal of Gynaecology and Obstetrics. 2009;104(2):100-4. 

  11. Kocken M, et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. The Lancet Oncology. 2011;12(5):441-50. 

  12. Bogani G, et al. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study. Gynecologic Oncology. 2020;159(3):636-41. 

  13. Strander B, et al. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ. 2007;335(7629):1077-80. 

  14. Heo KJ, A Study of External Treatment on the obstetric and gynecologic diseases, Daegu Haany University doctoral dissertation. 2007. 

  15. Yoo JE, Lee JY, Yoon YJ. A Review on Korean Traditional Medicine Research against Cervical Dysplasia - Focused on Studies of Cervical Cancer and Cervical Dysplasia. J Korean Obstet Gynecol. 2013;26(4):191-203. 

  16. Lee SJ, et al. Herbal Medicine for Cervical Intraepithelial Neoplasia After Loop Electrosurgical Excision Procedure: A Systematic Review and Meta-Analysis. J Korean Obstet Gynecol. 2020;33(2):44-62. 

  17. Lee E, Lee KY, Yu BK. 4 Cases of Traditional Korean Medicine Treatment for Patients with Surgical Margin Positive after LEEP in Cervical Intraepithelial Neoplasia. J Physiol & Pathol Korean Med. 2020;34(3):149-58. 

  18. van Hamont D, et al. Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia. Int J Gynecol Cancer. 2006;16(2):615-9. 

  19. Hormuzd A. Katki, et al. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. Journal of Lower Genital Tract Disease. 2013;17(5suppl):78-84. 

  20. Trottier H, et al. HPV infection and re-infection in adult women: the role of sexual activity and natural immunity. Cancer Res. 2010;70(21):8569-77. 

  21. Carter JJ, et al. Comparison of human papillomavirus types16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis. 2000;181(6):1911-9. 

  22. Kim MK, No JH, Song YS. Human Papillomavirus Vaccine. J Korean Med Assoc. 2009;52(12):1180-6. 

  23. Ghaem-Maghami S, et al. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncol. 2007;8(11):985-93. 

  24. The Society of Korean Medicine Obstetrics and Gynecology. Korean medicine Obstetrics & Gyenecology (Vol 2). 4th rev. Seoul:Euiseongdang. 2021:401. 

  25. Lee YJ. Antimetastatic Effects of Ojeoksan by Immunomodulation. KyungHee University doctoral dissertation. 2012. 

  26. Lee MJ, et al. Activation of Immune System & Antimetastatic Effects of Ojeok-san by Oral Administration. J Korean Obstet Gynecol. 2014;27(2):34-45. 

  27. Won HW, et al. Study of Developmental New Anti-cancer Prescription form Herbs of the activation of blood and the elimination of blood stasis. Korean J Oriental Physiology & Pathology. 2002;16(3):409-20. 

  28. Han JS, Park HS. The Effects of Anti-cancer and Immune Response of Lonicerae Flos Herbal-acupuncture. The Journal of Korean Acupuncture & Moxibustion Society. 2006;23(4):205-18. 

  29. Park JY, Park HS. Experimental Studies on Antimetastatic and Immunomodulating Effects of Patriniae Radix Herbalacupuncture. The Journal of Korean Acupuncture & Moxibustion Society. 2006;23(4):187-203. 

  30. So MS. Effect of Taraxacum mongolieum Hand-Mass on Proliferation of Breast Cancer Cells and Nitric Oxide Production. J Korean Health & Fundamental Med Sci. 2009;2(3):128-31. 

  31. Lee TH. Sa-am-do-in-chim-gu-yo-gyeol. Seoul:Haenglim. 1975:243. 

  32. Textbook Compilation Committee of Korean Acupunture and Moxibustion Medicine. Acupuncture Medicine. 1st rev. ed. Seoul:Hanmi Medical Publishing Co. 2016:105, 113. 

  33. Thies A, et al. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro. Toxicology. 2005;207(1):105-16. 

  34. Schaller G, Urech K, Giannattasio M. Cytotoxicity of different viscotoxins and extracts from the European subspecies of Viscum album L. Phyther Res. 1998;10(6):473-7. 

  35. Melo MNO, et al. Phenolic compounds from Viscum album tinctures enhanced antitumor activity in melanoma murine cancer cells. Saudi Pharm J. 2018;26(3):311-22. 

  36. Delebinski CI, et al. A natural combination extract of Viscum album L. containing both triterpene acids and lectins is highly effective against AML in vivo. PLoS ONE. 2015;10(8):e0133892. 

  37. Choi OB. The importance of clinical mistletoe cancer therapy and korean mistletoe pharmacopuncture preparation development and application possibility for oriental medicine. Journal of Pharmacopuncture. 2009;12(1):77-89. 

  38. Jin YJ, Shin KS, Ha JY. Case of Remission of Progressive Breast Cancer Treated by Capecitabine with Integrative Medicine Therapy. J Kor Traditional Oncology. 2014;19(1):43-51. 

  39. Yang JS, et al. A Case Report on the Therapeutic Effect of Integrated Cancer Therapy for Glioblastoma Multiforme. J Int Korean Med. 2022;43(2):320-5. 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로